» Articles » PMID: 36307508

Wildtype Heterogeneity Contributes to Clonal Variability in Genome Edited Cells

Abstract

Genome editing tools such as CRISPR/Cas9 enable the rapid and precise manipulation of genomes. CRISPR-based genome editing has greatly simplified the study of gene function in cell lines, but its widespread use has also highlighted challenges of reproducibility. Phenotypic variability among different knockout clones of the same gene is a common problem confounding the establishment of robust genotype-phenotype correlations. Optimized genome editing protocols to enhance reproducibility include measures to reduce off-target effects. However, even if current state-of-the-art protocols are applied phenotypic variability is frequently observed. Here we identify heterogeneity of wild-type cells as an important and often neglected confounding factor in genome-editing experiments. We demonstrate that isolation of individual wild-type clones from an apparently homogenous stable cell line uncovers significant phenotypic differences between clones. Strikingly, we observe hundreds of differentially regulated transcripts (477 up- and 306 downregulated) when comparing two populations of wild-type cells. Furthermore, we show a variety of cellular and biochemical alterations in different wild-type clones in a range that is commonly interpreted as biologically relevant in genome-edited cells. Heterogeneity of wild-type cells thus contributes to variability in genome-edited cells when these are generated through isolation of clones. We show that the generation of monoclonal isogenic wild-type cells prior to genomic manipulation reduces phenotypic variability. We therefore propose to generate matched isogenic control cells prior to genome editing to increase reproducibility.

Citing Articles

Posterior Limbal Mesenchymal Stromal Cells Promote Proliferation and Stemness of Transition Zone Cells: A Novel Insight Into Corneal Endothelial Rejuvenation.

Xiao Y, McGhee C, Zhang J Invest Ophthalmol Vis Sci. 2025; 66(1):44.

PMID: 39820276 PMC: 11753478. DOI: 10.1167/iovs.66.1.44.


Functional genomics screens reveal a role for TBC1D24 and SV2B in antibody-dependent enhancement of dengue virus infection.

Belmont L, Contreras M, Cartwright-Acar C, Marceau C, Agrawal A, Levoir L J Virol. 2024; 98(11):e0158224.

PMID: 39377586 PMC: 11578089. DOI: 10.1128/jvi.01582-24.


Generation and characterization of inducible KRAB-dCas9 iPSCs from primates for cross-species CRISPRi.

Edenhofer F, Termeg A, Ohnuki M, Jocher J, Kliesmete Z, Briem E iScience. 2024; 27(6):110090.

PMID: 38947524 PMC: 11214527. DOI: 10.1016/j.isci.2024.110090.


Rapid and Scalable Production of Functional SARS-CoV-2 Virus-like Particles (VLPs) by a Stable HEK293 Cell Pool.

Puarattana-Aroonkorn S, Tharakaraman K, Suriyawipada D, Ruchirawat M, Fuangthong M, Sasisekharan R Vaccines (Basel). 2024; 12(6).

PMID: 38932290 PMC: 11209123. DOI: 10.3390/vaccines12060561.


Characterization, Structure, and Inhibition of the Human Succinyl-CoA:glutarate-CoA Transferase, a Putative Genetic Modifier of Glutaric Aciduria Type 1.

Wu R, Khamrui S, Dodatko T, Leandro J, Sabovic A, Violante S ACS Chem Biol. 2024; 19(7):1544-1553.

PMID: 38915184 PMC: 11259535. DOI: 10.1021/acschembio.4c00204.


References
1.
Cai J, Song X, Wang W, Watnick T, Pei Y, Qian F . A RhoA-YAP-c-Myc signaling axis promotes the development of polycystic kidney disease. Genes Dev. 2018; 32(11-12):781-793. PMC: 6049514. DOI: 10.1101/gad.315127.118. View

2.
Artegiani B, Clevers H . Use and application of 3D-organoid technology. Hum Mol Genet. 2018; 27(R2):R99-R107. DOI: 10.1093/hmg/ddy187. View

3.
Yu S, Hackmann K, Gao J, Gao J, He X, Piontek K . Essential role of cleavage of Polycystin-1 at G protein-coupled receptor proteolytic site for kidney tubular structure. Proc Natl Acad Sci U S A. 2007; 104(47):18688-93. PMC: 2141838. DOI: 10.1073/pnas.0708217104. View

4.
Gaj T, Gersbach C, Barbas 3rd C . ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol. 2013; 31(7):397-405. PMC: 3694601. DOI: 10.1016/j.tibtech.2013.04.004. View

5.
Karlgren M, Simoff I, Backlund M, Wegler C, Keiser M, Handin N . A CRISPR-Cas9 Generated MDCK Cell Line Expressing Human MDR1 Without Endogenous Canine MDR1 (cABCB1): An Improved Tool for Drug Efflux Studies. J Pharm Sci. 2017; 106(9):2909-2913. DOI: 10.1016/j.xphs.2017.04.018. View